Delivery Order SPE2DB20D3103-SPE2DB24FP2M2
Award Date
6/20/24
Potential Completion Date
6/21/24
Potential Value
$4.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,414.58, is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of November 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $5,963.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4566175299 - OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, with an ultimate completion date of October 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,169.52 firm fixed-price delivery order covers the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product, with a period of performance through September 14, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,964.50 firm fixed-price delivery order is for the supply of 4566243184 OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, with a period of performance ending on October 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,643.00 firm-fixed-price delivery order is for the pharmaceutical product OVIDREL 250 MCG/0.5 ML SYRG 0.5ML. The contract has an ultimate completion date of April 17, 2024. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides the Defense Logistics Agency (DLA) Troop Support Medical with pharmaceutical products and medical supplies, primarily in the form of firm fixed price delivery orders. The award, valued at up to $3,964.50, is for the procurement of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a specialty pharmaceutical. The contract has an ultimate completion date of March 22, 2024 and was awarded on March...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The $1,789.07 firm fixed price delivery order is for 4563830856, described as OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, to be delivered by March 4, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,775.15 firm fixed price delivery order is for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a specialty pharmaceutical product, with an ultimate completion date of November 1, 2024. AmerisourceBergen holds two relevant Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal Bureau...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,734.40 firm fixed-price delivery order contract covers the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a specialty medication, to support military healthcare programs. The award is a child contract under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
The federal contract award with ID SPE2DB22D3501|SPE2DB24FVJ38 is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,585.80 firm-fixed-price contract is for the supply of 4,564,340,496 units of the pharmaceutical product OVIDREL 250 MCG/0.5 ML SYRG 0.5ML. The award has an ultimate completion date of April 22, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery...